Diabetes mellitus and the β cell: the last ten years.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22424227.
- Also identified by DOI 10.1016/j.cell.2012.02.010 and PMC identifier 5890906.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diabetes is a major global problem. During the past decade, the genetic basis of various monogenic forms of the disease, and their underlying molecular mechanisms, have been elucidated. Many genes that increase type 2 diabetes (T2DM) risk have also been identified, but how they do so remains enigmatic. Nevertheless, defective insulin secretion emerges as the main culprit in both monogenic and polygenic diabetes, with environmental and lifestyle factors, via obesity, accounting for the current dramatic increase in T2DM. There also have been significant advances in therapy, particularly for some monogenic disorders. We review here what ails the β cell and how its function may be restored.
Medical subject headings
- Diabetes Mellitus, Type 2
- Insulin-Secreting Cells